OpenAI宣布推出GPT-4 Turbo 迄今最強大AI 可建立自訂版本ChatGPT
微軟(MSFT.US)支持的OpenAI周一(6日)在其首次現場活動中發布其最新及更強大的GPT-4 Turbo人工智能(AI)模型,並提供新選項,允許用戶創建其ChatGPT聊天機械人的自訂版本,而且調低公司和開發商運行其軟體的收費。
OpenAI表示,ChatGPT在推出幾個月後就打破了歷史上成長最快的消費者應用程式的記錄,目前每周活躍用戶約為1億。超過92%的財富500強公司使用該平台,高於8月時80%。
微軟執行長納德拉(Satya Nadella)於活動中亦有現身。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.